BioSpace News Archive

Aarvik Therapeutics , a biotechnology company dedicated to engineering precision therapies for oncology targets, has undergone a name change from Aarkus Therapeutics, effective immediately.

This new patent continues to expand the broad reach of Relay’s intellectual property portfolio for its diagnostics and analysis platforms in the rapidly growing IoT (“internet-of-things”) healthcare market.

Plasma therapy is one of the conservative techniques that is majorly used in dentistry, orthopedic, and dermatologic specialties.

Hepagene Therapeutics, Inc. today announced positive results from its Phase I study of HPG1860 conducted in the United States .

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty

Today, LG Chem Life Sciences Innovation Center announces that it has selected Thymmune Therapeutics as the winner of their 2021 Golden Ticket Program.

Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced that the renowned Dr. Anna Suk-Fong Lok, MD, has joined the Scientific Advisory Board for a potential cure for Hepatitis B Virus (HBV), that causes liver disease in approximately 350 million people globally and 1 million deaths every year.

High prevalence of hematologic diseases, rise in accidents, and growth in geriatric population drive the global blood bank market

Increase in trends of outsourcing services owing to benefits offered by outsourced compliance providers over in-house compliance functions, and increase in adverse drug reactions and drug toxicity, boost growth of the market.

Entera Bio Ltd. today announced it will host its annual shareholders meeting on Monday, October 4, 2021.